Pharma companies bet on flagship products to grow in strength

Indian drug manufacturers are utilizing flagship products or "mother brands" to introduce new combinations and establish leadership in therapy areas, as per research by Pharmarack. For example, USV's anti-diabetes drug Glycomet has bolstered the company's reputation in diabetic therapy and facilitated partnerships with multinational drugmakers for innovative therapies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ORC4Jvs
via IFTTT